Quantitative structure–activity relationships study of potent pyridinone scaffold derivatives as HIV-1 integrase inhibitors with therapeutic applications

2017 ◽  
Vol 16 (05) ◽  
pp. 1750038 ◽  
Author(s):  
Abolfazl Barzegar ◽  
Hossein Hamidi

Human immunodeficiency virus-1 (HIV-1) integrase appears to be a crucial target for developing new anti-HIV-1 therapeutic agents. Different quantitative structure–activity relationships (QSARs) algorithms have been used in order to develop efficient model(s) to predict the activity of new pyridinone derivatives against HIV-1 integrase. Multiple linear regression (MLR) and combined principal component analysis (PCA) with MLR have been applied to build QSAR models for a set of new pyridinone derivatives as potent anti-HIV-1 therapeutic agents. Four different approaches based on MLR method including; concrete-MLR, stepwise-MLR, concrete PCA–MLR and stepwise PCA–MLR were utilized for this aim. Twenty two different sets of descriptors containing 1613 descriptors were constructed for each optimized molecule. Comparison between predictability of the “concrete” and “stepwise” procedure in two different algorithms of MLR and PCA models indicated the advantage of the stepwise procedure over that of the simple concrete method. Although the PCA was employed for dimension reduction, using stepwise PCA–MLR model showed that the method has higher ability to predict the compounds’ activity. The stepwise PCA–MLR model showed highly validated statistical results both in fitting and prediction processes ([Formula: see text] and [Formula: see text]). Therefore, using stepwise PCA approach is suitable to remove ineffective descriptors, which results in remaining efficient descriptors for building good predictability stepwise PCA–MLR. The stepwise hybrid approach of PCA–MLR may be useful in derivation of highly predictive and interpretable QSAR models.

Nanoscale ◽  
2016 ◽  
Vol 8 (13) ◽  
pp. 7203-7208 ◽  
Author(s):  
Natalia Sizochenko ◽  
Agnieszka Gajewicz ◽  
Jerzy Leszczynski ◽  
Tomasz Puzyn

In this paper, we suggest that causal inference methods could be efficiently used in Quantitative Structure–Activity Relationships (QSAR) modeling as additional validation criteria within quality evaluation of the model.


2009 ◽  
Vol 2 (3) ◽  
pp. 184-186 ◽  
Author(s):  
Miloň Tichý ◽  
Marián Rucki

Validation of QSAR models for legislative purposesOECD principles of validation of Quantitative Structure - Activity Relationships (QSAR) models for legislative purposes are given and explained. Reasons of their origination and development, like system REACH, are described. A basic impulse has come from some OECD countries followed by all (almost) other countries of the world.


2019 ◽  
Author(s):  
Yu Wei ◽  
Wei Li ◽  
Tengfei Du ◽  
Zhangyong Hong ◽  
Jianping Lin

ABSTRACTCo-infection between HIV-1 and HCV is common today in certain populations. However, treatment of co-infection is full of challenges with special consideration for potential hepatic safety and drug-drug interactions. Multitarget inhibitors with less toxicity may provide a promising therapeutic strategy for HIV/HCV co-infection. However, identification of one molecule acting on multiple targets simultaneously by experimental evaluation is costly and time-consuming. In silico target prediction tools provide more opportunities for the development of multitarget inhibitors. In this study, by combining naive Bayesian (NB) and support vector machine (SVM) algorithms with two types of molecular fingerprints (MACCS and ECFP6), 60 classification models were constructed to predict the active compounds toward 11 HIV-1 targets and 4 HCV targets based on the multitarget-quantitative structure-activity relationships (mt-QSAR). 5-fold cross-validation and test set validation was performed to confirm the performance of 60 classification models. Our results show that 60 mt-QSAR models appeared to have high classification accuracy in terms of ROC-AUC values ranging from 0.83 to 1 with a mean value of 0.97 for HIV-1 models, and ROC-AUC values ranging from 0.84 to 1 with a mean value of 0.96 for HCV. Furthermore, the 60 models were applied to comprehensively predict the potential targets for additional 46 compounds including 27 approved HIV-1 drugs, 10 approved HCV drugs and 9 selected compounds known to be active on one or more targets of HIV-1 or those of HCV. Finally, 18 hits including 7 HIV-1 approved drugs, 4 HCV approved drugs and 7 compounds were predicted to be HIV/HCV co-infection multitarget inhibitors. The reported bioactivity data confirmed that 7 compounds actually interacted with HIV-1 and HCV targets simultaneously with diverse binding affinities. Of those remaining predicted hits and chemical-protein interaction pairs involving the potential ability to suppress HIV/HCV co-infection deserve further investigation by experiments. This investigation shows that the mt-QSAR method is available to predict chemical-protein interaction for discovering multitarget inhibitors and provide a unique perspective on HIV/HCV co-infection treatment.


Sign in / Sign up

Export Citation Format

Share Document